Metabolic syndrome and associated kidney disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

With the rise in the incidence of childhood obesity, it is increasinglyevident that the burden of chronic kidney disease (CKD) has increased proportionately and has its origins in early life. This chapter will discuss the central role of the kidney in the mediation of elements of the metabolic syndrome (MetS) including glucose disposal, hyperinsulinemia, uric acid excretion, and the renin-angiotensin-aldosterone system (RAAS). There is evidence that an adverse fetal environment with accelerated postnatal growth may contribute to a low nephron “endowment” and predispose to MetS and CKD in later life. The focus will be on the primary end points of hypertension, proteinuria, hyperuricemia, urolithiasis, and CKD. We will provide recommended treatment strategies and discuss necessary future research projects related to the MetS and CKD in children and adolescents.

Original languageEnglish (US)
Title of host publicationPediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues
PublisherSpringer-Verlag London Ltd
Pages117-136
Number of pages20
ISBN (Print)9781447123668, 9781447123651
DOIs
StatePublished - Jan 1 2012

Fingerprint

Kidney Diseases
Chronic Renal Insufficiency
Hyperuricemia
Urolithiasis
Pediatric Obesity
Nephrons
Hyperinsulinism
Financial Management
Renin-Angiotensin System
Uric Acid
Proteinuria
Hypertension
Kidney
Glucose
Incidence
Growth
Therapeutics

Keywords

  • Fetal programming
  • Hypertension
  • Hyperuricemia
  • Obesity-related glomerulopathy (ORG)
  • Proteinuria

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Abitbol, C., & Seeherunvong, W. (2012). Metabolic syndrome and associated kidney disease. In Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues (pp. 117-136). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-2366-8_6

Metabolic syndrome and associated kidney disease. / Abitbol, Carolyn; Seeherunvong, Wacharee.

Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues. Springer-Verlag London Ltd, 2012. p. 117-136.

Research output: Chapter in Book/Report/Conference proceedingChapter

Abitbol, C & Seeherunvong, W 2012, Metabolic syndrome and associated kidney disease. in Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues. Springer-Verlag London Ltd, pp. 117-136. https://doi.org/10.1007/978-1-4471-2366-8_6
Abitbol C, Seeherunvong W. Metabolic syndrome and associated kidney disease. In Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues. Springer-Verlag London Ltd. 2012. p. 117-136 https://doi.org/10.1007/978-1-4471-2366-8_6
Abitbol, Carolyn ; Seeherunvong, Wacharee. / Metabolic syndrome and associated kidney disease. Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues. Springer-Verlag London Ltd, 2012. pp. 117-136
@inbook{f938dd4884ea4a1fbf7d226ceda7bcd2,
title = "Metabolic syndrome and associated kidney disease",
abstract = "With the rise in the incidence of childhood obesity, it is increasinglyevident that the burden of chronic kidney disease (CKD) has increased proportionately and has its origins in early life. This chapter will discuss the central role of the kidney in the mediation of elements of the metabolic syndrome (MetS) including glucose disposal, hyperinsulinemia, uric acid excretion, and the renin-angiotensin-aldosterone system (RAAS). There is evidence that an adverse fetal environment with accelerated postnatal growth may contribute to a low nephron “endowment” and predispose to MetS and CKD in later life. The focus will be on the primary end points of hypertension, proteinuria, hyperuricemia, urolithiasis, and CKD. We will provide recommended treatment strategies and discuss necessary future research projects related to the MetS and CKD in children and adolescents.",
keywords = "Fetal programming, Hypertension, Hyperuricemia, Obesity-related glomerulopathy (ORG), Proteinuria",
author = "Carolyn Abitbol and Wacharee Seeherunvong",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-2366-8_6",
language = "English (US)",
isbn = "9781447123668",
pages = "117--136",
booktitle = "Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Metabolic syndrome and associated kidney disease

AU - Abitbol, Carolyn

AU - Seeherunvong, Wacharee

PY - 2012/1/1

Y1 - 2012/1/1

N2 - With the rise in the incidence of childhood obesity, it is increasinglyevident that the burden of chronic kidney disease (CKD) has increased proportionately and has its origins in early life. This chapter will discuss the central role of the kidney in the mediation of elements of the metabolic syndrome (MetS) including glucose disposal, hyperinsulinemia, uric acid excretion, and the renin-angiotensin-aldosterone system (RAAS). There is evidence that an adverse fetal environment with accelerated postnatal growth may contribute to a low nephron “endowment” and predispose to MetS and CKD in later life. The focus will be on the primary end points of hypertension, proteinuria, hyperuricemia, urolithiasis, and CKD. We will provide recommended treatment strategies and discuss necessary future research projects related to the MetS and CKD in children and adolescents.

AB - With the rise in the incidence of childhood obesity, it is increasinglyevident that the burden of chronic kidney disease (CKD) has increased proportionately and has its origins in early life. This chapter will discuss the central role of the kidney in the mediation of elements of the metabolic syndrome (MetS) including glucose disposal, hyperinsulinemia, uric acid excretion, and the renin-angiotensin-aldosterone system (RAAS). There is evidence that an adverse fetal environment with accelerated postnatal growth may contribute to a low nephron “endowment” and predispose to MetS and CKD in later life. The focus will be on the primary end points of hypertension, proteinuria, hyperuricemia, urolithiasis, and CKD. We will provide recommended treatment strategies and discuss necessary future research projects related to the MetS and CKD in children and adolescents.

KW - Fetal programming

KW - Hypertension

KW - Hyperuricemia

KW - Obesity-related glomerulopathy (ORG)

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=84955392940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955392940&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-2366-8_6

DO - 10.1007/978-1-4471-2366-8_6

M3 - Chapter

AN - SCOPUS:84955392940

SN - 9781447123668

SN - 9781447123651

SP - 117

EP - 136

BT - Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues

PB - Springer-Verlag London Ltd

ER -